Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
Ytterberg SR, Bhatt DL, Mikuls TR, Koch GG, Fleischmann R, Rivas JL, Germino R, Menon S, Sun Y, Wang C, Shapiro AB, Kanik KS, Connell CA; ORAL Surveillance Investigators. Ytterberg SR, et al. N Engl J Med. 2022 Jan 27;386(4):316-326. doi: 10.1056/NEJMoa2109927. N Engl J Med. 2022. PMID: 35081280 Clinical Trial.
Germline-somatic JAK2 interactions are associated with clonal expansion in myelofibrosis.
Brown DW, Zhou W, Wang Y, Jones K, Luo W, Dagnall C, Teshome K, Klein A, Zhang T, Lin SH, Lee OW, Khan S, Vo JB, Hutchinson A, Liu J, Wang J, Zhu B, Hicks B, Martin AS, Spellman SR, Wang T, Deeg HJ, Gupta V, Lee SJ, Freedman ND, Yeager M, Chanock SJ, Savage SA, Saber W, Gadalla SM, Machiela MJ. Brown DW, et al. Among authors: vo jb. Nat Commun. 2022 Sep 8;13(1):5284. doi: 10.1038/s41467-022-32986-7. Nat Commun. 2022. PMID: 36075929 Free PMC article.
Endocrine therapy initiation among women with stage I-III invasive, hormone receptor-positive breast cancer from 2001-2016.
Bowles EJA, Ramin C, Buist DSM, Feigelson HS, Weinmann S, Veiga LHS, Bodelon C, Curtis RE, Vo JB, Berrington de Gonzalez A, Gierach GL. Bowles EJA, et al. Among authors: vo jb. Breast Cancer Res Treat. 2022 May;193(1):203-216. doi: 10.1007/s10549-022-06561-z. Epub 2022 Mar 11. Breast Cancer Res Treat. 2022. PMID: 35275285 Free PMC article.
The influence of treatment on hormone receptor subgroups and breast cancer-specific mortality within US integrated healthcare systems.
Ramin C, Gierach GL, Abubakar M, Veiga LHS, Vo JB, Curtis RE, Bowles EJA, Feigelson HS, Buist DSM, Berrington de Gonzalez A, Bodelon C. Ramin C, et al. Among authors: vo jb. Cancer Causes Control. 2022 Jul;33(7):1019-1023. doi: 10.1007/s10552-022-01589-4. Epub 2022 May 18. Cancer Causes Control. 2022. PMID: 35583697 Free PMC article.
Correction to: The influence of treatment on hormone receptor subgroups and breast cancer-specific mortality within US integrated healthcare systems.
Ramin C, Gierach GL, Abubakar M, Veiga LHS, Vo JB, Curtis RE, Bowles EJA, Feigelson HS, Buist DSM, de Gonzalez AB, Bodelon C. Ramin C, et al. Among authors: vo jb. Cancer Causes Control. 2023 Jan;34(1):101-102. doi: 10.1007/s10552-022-01627-1. Cancer Causes Control. 2023. PMID: 36214934 Free PMC article. No abstract available.
39 results